8-K - Liminatus Pharma, Inc. (0001971387) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Liminatus Pharma filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- LIMN Liminatus Pharma
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- LLY Eli Lilly and+20.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- PFE Pfizer+9.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- MRK Merck+3.3% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LIMN | +16.27% | +10.12% | base | after close | after close | after close | after close |
| XLV | -2.42% | +0.36% | base | after close | after close | after close | after close |
| XBI | +1.67% | +0.67% | base | after close | after close | after close | after close |
| LLY | -8.25% | +0.73% | base | after close | after close | after close | after close |
| JNJ | +2.19% | +2.93% | base | after close | after close | after close | after close |
| PFE | -1.47% | +1.94% | base | after close | after close | after close | after close |
| MRK | -1.72% | +4.16% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001104659-26-122012 Size: 461 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Liminatus Pharma (LIMNW) has moved since 3 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | +2.93% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +2.19% | final price |
| LIMN | three days earlier | +10.12% | final price |
| LIMN | five days earlier | +16.27% | final price |
| Eli Lilly (LLY) | three days earlier | +0.73% | final price |
| Eli Lilly (LLY) | five days earlier | -8.25% | final price |
| Merck (MRK) | three days earlier | +4.16% | final price |
| Merck (MRK) | five days earlier | -1.72% | final price |
| Pfizer (PFE) | three days earlier | +1.94% | final price |
| Pfizer (PFE) | five days earlier | -1.47% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.67% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.67% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.36% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.42% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 56 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 74 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Liminatus Pharma, Inc. (0001971387) (Filer)”
Companies tied to this story
- LIMNW Liminatus Pharma
For “8-K - Liminatus Pharma, Inc. (0001971387) (Filer),” Liminatus Pharma (LIMNW) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> LIMNW
- XLV Select Sector Spdr Tr
For “8-K - Liminatus Pharma, Inc. (0001971387) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- XBI Spdr Series Trust
For “8-K - Liminatus Pharma, Inc. (0001971387) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- LLY Eli Lilly
For “8-K - Liminatus Pharma, Inc. (0001971387) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 3 Nov 2026 story “8-K - Liminatus Pharma, Inc. (0001971387) (Filer).” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- PFE Pfizer
For “8-K - Liminatus Pharma, Inc. (0001971387) (Filer),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 3 Nov 2026 story “8-K - Liminatus Pharma, Inc. (0001971387) (Filer).” Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
How “8-K - Liminatus Pharma, Inc. (0001971387) (Filer)” reaches Liminatus Pharma (LIMNW)
“8-K - Liminatus Pharma, Inc. (0001971387) (Filer)” (3 Nov 2026) reaches Liminatus Pharma (LIMNW) through this story.
The link for Liminatus Pharma (LIMNW) is this: SEC 8-K filing -> direct issuer disclosure -> LIMNW
Select Sector Spdr Tr (XLV) is here too. Its reason reads: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
How strong the case is around Liminatus Pharma (LIMNW)
46 out of 100
“8-K - Liminatus Pharma, Inc. (0001971387) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.